It is now possible to combine antigens with specific adjuvant systems to create more effective vaccines.
Alberta Di Pasquale, PhD
Advertisement
Alberta Di Pasquale, PhD, is the director of global medical affairs at GlaxoSmithKline Biologicals
Articles by Alberta Di Pasquale, PhD
Advertisement
Latest Updated Articles
Addressing Unmet Medical Needs Through Tailored Vaccine Design: The Importance of Adjuvant SystemsPublished: October 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain
2
Q&A: Strategies for Supply Chain Resilience and Next-Generation Process Optimization
3
BioPharm Weekly News Roundup—Week of Oct. 27, 2025
4
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
5
